

Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.451, 2004-01, pp. : 3-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Olopatadine improves symptoms, QOL in seasonal allergic rhinitis
Inpharma, Vol. 1, Iss. 1434, 2004-01 ,pp. :




By Scadding Glenis K Keith Paul K
Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 15, 2008-10 ,pp. :


Allergic conjunctivitis: improved QOL with olopatadine plus loratadine
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 326, 2001-01 ,pp. :